Tumor microenvironment and myeloid-derived suppressor cells.
about
Myeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implicationsIL-17/miR-192/IL-17Rs regulatory feedback loop facilitates multiple myeloma progressionMicroRNA-155 deficiency enhances the recruitment and functions of myeloid-derived suppressor cells in tumor microenvironment and promotes solid tumor growth.Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosis.The role of complement in tumor growthCD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancerCase-control estimation of the impact of oncolytic adenovirus on the survival of patients with refractory solid tumorsReprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells.Targeting IL4/IL4R for the treatment of epithelial cancer metastasis.T Cell Intrinsic USP15 Deficiency Promotes Excessive IFN-γ Production and an Immunosuppressive Tumor Microenvironment in MCA-Induced FibrosarcomaMyeloid-derived suppressor cells enhance the expression of melanoma-associated antigen A4 in a Lewis lung cancer murine modelNodal metastasis in cervical cancer occurs in clearly delineated fields of immune suppression in the pelvic lymph catchment areaMechanisms of action of tasquinimod on the tumour microenvironment.Microenvironmental clues for glioma immunotherapy.The potential to target CCL5/CCR5 in breast cancer.Upregulation of T-cell Immunoglobulin and Mucin-Domain Containing-3 (Tim-3) in Monocytes/Macrophages Associates with Gastric Cancer Progression.Aminoacyl-tRNA synthetase-interacting multifunctional protein 1 suppresses tumor growth in breast cancer-bearing mice by negatively regulating myeloid-derived suppressor cell functions.Tumour-activated liver stromal cells regulate myeloid-derived suppressor cells accumulation in the liver.Toxicity of metronomic cyclophosphamide chemotherapy in a UK population of cancer-bearing dogs: a retrospective study.The use of low-dose metronomic chemotherapy in dogs-insight into a modern cancer field.Overcoming the resistance of pancreatic cancer to immune checkpoint inhibitors.IFN-α-based treatment of patients with chronic HCV show increased levels of cells with myeloid-derived suppressor cell phenotype and of IDO and NOS.Downregulation of ADAM10 expression inhibits metastasis and invasiveness of human hepatocellular carcinoma HepG2 cells.Location, location, location: functional and phenotypic heterogeneity between tumor-infiltrating and non-infiltrating myeloid-derived suppressor cells.Activation of VIP signaling enhances immunosuppressive effect of MDSCs on CMV-induced adaptive immunity.BRAF peptide vaccine facilitates therapy of murine BRAF-mutant melanoma.A Retroviral Replicating Vector Encoding Cytosine Deaminase and 5-FC Induces Immune Memory in Metastatic Colorectal Cancer Models.Myeloid-derived suppressor cells coming of age.Malignant Astrocytic Tumor Progression Potentiated by JAK-mediated Recruitment of Myeloid Cells.The role of immune cell subpopulations in the growth and rejection of TC-1/A9 tumors in novel mouse strains differing in the H2-D haplotype and NKC domain.Immune Cell Infiltrates in Pituitary Adenomas: More Macrophages in Larger Adenomas and More T Cells in Growth Hormone Adenomas.Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells.Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression.Presence of Infected Gr-1CD11bCD11c Monocytic Myeloid Derived Suppressor Cells Subverts T Cell Response and Is Associated With Impaired Dendritic Cell Function in -Infected Mice
P2860
Q27014189-005610D4-8124-43EB-A426-B8DC1B0FADB7Q34663126-AB39FD0E-9DC7-48F9-94F1-38AF8F890A86Q34899627-F1BA219D-0F08-44EF-8906-724447B5FB92Q35056748-5B71B08B-7557-42C5-984D-4BDA6AA93AC4Q35231345-ECC1D952-8F26-4B13-901E-62C6BF56D723Q35485418-90330522-9527-4144-94B6-8370ECFAC178Q35653264-9BC64C8C-EC88-40D7-98BB-49A37EBEC567Q35799094-647872DF-C813-4D36-9A6B-46E08F0B2EA8Q36296416-FF213E2A-6AB9-4116-8B23-B55B4C85F5DAQ36405486-C6D59252-29BE-4960-A163-B54D66D6C778Q36503123-39187387-E70C-4F8B-9779-7C6270DAF758Q36544888-25E4F902-E9DE-4476-854A-3E49F11E0FC7Q38155757-3E6653CF-171B-4315-A514-697E3E192BBBQ38194054-9305483C-F88C-410C-8231-1623BF770CBBQ38254356-D854ED4B-C11D-43C6-B1EE-C326A313369AQ38727915-FDA64A08-10AB-4DAB-9040-C6D73B8916CCQ38816155-74A5FCE0-A796-4AB9-A7FC-563DDE5E1441Q39064350-2C23C660-5584-4D82-91A3-437540269BD8Q39108682-22A3CE0F-C169-4398-8193-BD6247AA811CQ39186863-4CAF7387-EBD0-476E-AED3-BF7E058DE064Q39383207-2FC2721A-3F25-414A-A130-C37C46E54A96Q39424862-3B1951FA-85F5-4DA8-B7C1-05E32A0C1216Q42087031-AA03B0AF-A2C1-4C4A-B6EF-291913BE5FA3Q42840029-C52B9F31-F86E-4FAC-AB78-61F19B88D5B3Q46831751-F0D51614-4B85-4B18-96BB-FEB003BCD41CQ47389306-D8491BFA-30FA-404A-A834-77462B12905AQ47739279-9A27B746-7F27-46E0-8CC4-92B2E885BB06Q48215791-C25D5081-35D6-4A6A-B35D-434C36BA3F88Q49510141-1CCE802D-6254-4CAE-9C9E-3D1F807C18BDQ50175409-C221BC1D-C855-46B0-9B2B-6A5D70CD6095Q52151895-50CDABA8-AD72-4471-8BE1-66A2EC7B47ABQ52597550-D98762C4-83F6-4A7C-82C5-04A3F778BF33Q55265921-CC766F8C-C1C5-49AD-924C-C629CC61791EQ58553806-A60486D6-86D6-44DA-A323-AEB569A224E2
P2860
Tumor microenvironment and myeloid-derived suppressor cells.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Tumor microenvironment and myeloid-derived suppressor cells.
@en
type
label
Tumor microenvironment and myeloid-derived suppressor cells.
@en
prefLabel
Tumor microenvironment and myeloid-derived suppressor cells.
@en
P2860
P1433
P1476
Tumor microenvironment and myeloid-derived suppressor cells.
@en
P2093
Alexandra Sevko
Viktor Umansky
P2860
P2888
P304
P356
10.1007/S12307-012-0126-7
P577
2012-12-16T00:00:00Z
P5875
P6179
1033961634